Key result
High-frequency ultrasound imaging with a novel size-tuned microbubble contrast agent enabled quantitative assessment of myocardial perfusion and identification of altered perfusion in infarcted mice.
Why the study?
Does a novel size-tuned microbubble contrast agent with ultra-high-frequency ultrasound improve quantitative assessment of myocardial perfusion in mice?
Does a novel size-tuned microbubble contrast agent with ultra-high-frequency ultrasound improve quantitative assessment of myocardial perfusion in mice?
A novel size-tuned microbubble contrast agent and time-domain reslicing method enables quantitative assessment of myocardial perfusion and infarct size in mice using ultra-high-frequency ultrasound.
Does not yet inform clinical care; extends quantitative perfusion imaging to murine infarction models.
The small size of the mouse heart frequently imparts technical challenges when applying conventional in vivo imaging methods for assessing heart function. Here, we describe the use of high-frequency ultrasound imaging in conjunction with a size-tuned blood pool contrast agent for quantitatively assessing myocardial perfusion in living mice. A perflurocarbon microbubble formulation exhibiting a narrow size distribution was developed, and echogenicity was assessed at 18 MHz in vitro. Adult mice were subjected to permanent ligation of the left anterior descending artery. Ultrasound imaging was performed on day 7, and a cohort of intact mice was used as a control. Parasternal long-axis cine clips were acquired at 18 MHz before and after contrast administration. Reduced ejection fraction and increased end-systolic volume were observed in infarcted compared with control mice. In control animals, washin of the contrast agent was visible in all myocardial segments. Reduced contrast enhancement was observed in apical-posterolateral regions of all infarcted mice. A novel method for reslicing of the imaging data through the time domain provided a two-dimensional presentation of regional contrast agent washin, enabling convenient identification of locations exhibiting altered perfusion. Myocardial segments exhibiting diminished contractility were observed to have correspondingly low relative myocardial perfusion. The contrast agent formulation and methods demonstrated here provide the basis for simplifying routine in vivo estimation of infarct size in mice and may be particularly useful in longitudinal evaluation of revascularization interventions and assessment of peri-infarct ischemia. NEW & NOTEWORTHY Murine myocardial contrast echocardiography frequently suffers from poor sensitivity to contrast. Here, we formulated a novel size-tuned microbubble contrast agent and validated it for use with ultra-high-frequency ultrasound. A novel data method for evaluating myocardial perfusion based on reslicing the imaging data through the time domain is presented.
No takes yet. Share an insight, caveat, or question.
Alvarez et al. (2017) studied Myocardial infarction. High-frequency ultrasound imaging with a size-tuned blood pool contrast agent vs. Intact control mice was evaluated on Myocardial perfusion and heart function. High-frequency ultrasound imaging with a novel size-tuned microbubble contrast agent enabled quantitative assessment of myocardial perfusion and identification of altered perfusion in infarcted mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: